{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:40:20Z","timestamp":1787010020526,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1097\/ico.0000000000000336","type":"journal-article","created":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T03:07:43Z","timestamp":1423019263000},"page":"449-455","source":"Crossref","is-referenced-by-count":27,"title":["Comparative Study of Tacrolimus and Bevacizumab on Corneal Neovascularization in Rabbits"],"prefix":"10.1097","volume":"34","author":[{"given":"Jin-Heung","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choun-Ki","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Kun","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20210204","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.survophthal.2012.01.007","article-title":". Corneal neovascularization: an anti-VEGF therapy review.","volume":"57","author":"Chang","year":"2012","journal-title":"Surv Ophthalmol"},{"key":"R2-16-20210204","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/ICO.0b013e318201405a","article-title":"Treatments for corneal neovascularization: a review.","volume":"30","author":"Gupta","year":"2011","journal-title":"Cornea"},{"key":"R3-16-20210204","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/ICO.0b013e3182775f8d","article-title":". Topical ranibizumab as a treatment of corneal neovascularization.","volume":"32","author":"Ferrari","year":"2013","journal-title":"Cornea"},{"key":"R4-16-20210204","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jtos.2012.01.005","article-title":". Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin).","volume":"10","author":"Stevenson","year":"2012","journal-title":"Ocul Surf"},{"key":"R5-16-20210204","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10792-013-9732-8","article-title":"The effect of different doses of subconjunctival bevacizumab injection on corneal neovascularization.","volume":"33","author":"Acar","year":"2013","journal-title":"Int Ophthalmol"},{"key":"R6-16-20210204","first-page":"136","article-title":". Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model.","volume":"6","author":"Akar","year":"2013","journal-title":"Int J Ophthalmol"},{"key":"R7-16-20210204","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/ICO.0000000000000007","article-title":"Comparative study of ranibizumab and bevacizumab on corneal neovascularization in rabbits.","volume":"33","author":"Kim","year":"2014","journal-title":"Cornea"},{"key":"R8-16-20210204","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1097\/ICO.0b013e318292a79d","article-title":"The inhibitory effect of thalidomide analogue on corneal neovascularization in rabbits.","volume":"32","author":"Lee","year":"2013","journal-title":"Cornea"},{"key":"R9-16-20210204","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jcjo.2012.12.003","article-title":". Effects of subconjunctivally injected bevacizumab, etanercept, and the combination of both drugs on experimental corneal neovascularization.","volume":"48","author":"Ozdemir","year":"2013","journal-title":"Can J Ophthalmol"},{"key":"R10-16-20210204","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1159\/000356407","article-title":". High-dose topical bevacizumab for corneal neovascularization.","volume":"92","author":"Waisbourd","year":"2013","journal-title":"Pharmacology"},{"key":"R11-16-20210204","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/ICO.0b013e31823f8b40","article-title":". Activated macrophages induce neovascularization through upregulation of MMP-9 and VEGF in rat corneas.","volume":"31","author":"Li","year":"2012","journal-title":"Cornea"},{"key":"R12-16-20210204","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1089\/jop.2008.0125","article-title":". Preparation of 0.05 FK506 suspension eyedrops and its pharmacokinetics after topical ocular administration.","volume":"25","author":"Yuan","year":"2009","journal-title":"J Ocul Pharmacol Ther"},{"key":"R13-16-20210204","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/jop.2007.0059","article-title":". Preliminary study of the effect of FK506 nanospheric-suspension eye drops on rejection of penetrating keratoplasty.","volume":"24","author":"Fei","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"R14-16-20210204","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/02713683.2010.516620","article-title":". The impact of tacrolimus on vascular endothelial growth factor in experimental corneal neovascularization.","volume":"36","author":"Turgut","year":"2011","journal-title":"Curr Eye Res"},{"key":"R15-16-20210204","first-page":"12","article-title":". Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty.","volume":"39","author":"Minamoto","year":"1995","journal-title":"Jap J Ophthalmol"},{"key":"R16-16-20210204","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/jop.2007.0086","article-title":". Absorption, distribution, and excretion of 14C-labeled tacrolimus (FK506) after a single or repeated ocular instillation in rabbits.","volume":"24","author":"Fujita","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"R17-16-20210204","doi-asserted-by":"crossref","first-page":"4807","DOI":"10.1167\/iovs.08-3148","article-title":". Pharmacokinetics of bevacizumab after topical, subconjunctival, and intravitreal administration in rabbits.","volume":"50","author":"Nomoto","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-16-20210204","doi-asserted-by":"crossref","first-page":"6502","DOI":"10.1016\/j.actbio.2013.01.022","article-title":". Macrophage phenotypes in the collagen-induced foreign body reaction in rats.","volume":"9","author":"Van Putten","year":"2013","journal-title":"Acta Biomater"},{"key":"R19-16-20210204","first-page":"1614","article-title":". Essential contribution of CCL3 to alkali-induced corneal neovascularization by regulating vascular endothelial growth factor production by macrophages.","volume":"14","author":"Lu","year":"2008","journal-title":"Mol Vis"},{"key":"R20-16-20210204","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1167\/iovs.11-8114","article-title":". Larger therapeutic window for steroid versus VEGF-A inhibitor in inflammatory angiogenesis: surprisingly similar impact on leukocyte infiltration.","volume":"53","author":"Nakao","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-16-20210204","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/978-1-4939-0928-5_29","article-title":"Chromatin immunoprecipitation analysis of bortezomib-mediated inhibition of NFB recruitment to IL-1 and TNF gene Promoters in human macrophages.","volume":"1172","author":"Sanacora","year":"2014","journal-title":"Methods Mol Biol"},{"key":"R22-16-20210204","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00417-007-0684-4","article-title":". Bevacizumab (Avastin) eye drops inhibit corneal neovascularization.","volume":"246","author":"Bock","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R24-16-20210204","first-page":"469","article-title":". Usefulness of a slow-release tacrolimus for a patient with tacrolimus-induced renal injury after hemopoietic stem cell transplantation.","volume":"53","author":"Hosonuma","year":"2012","journal-title":"Rinsho Ketsueki"},{"key":"R25-16-20210204","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/dth.12068","article-title":"Anogenital epidermolytic acanthomas: effective treatment of pruritus with 0.1 tacrolimus ointment.","volume":"27","author":"Tan","year":"2014","journal-title":"Dermatol Ther"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0000000000000336","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T21:10:57Z","timestamp":1620940257000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201504000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0000000000000336","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}